Document Detail

Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
MedLine Citation:
PMID:  23387899     Owner:  NLM     Status:  Publisher    
Human carbonic anhydrase (hCA) IX is involved in tumorigenesis and metastasis through pathways modulating extracellular pH regulation and cell adhesion control. As a consequence, hCA IX represents a promising antitumor target for the development of new drugs in order to treat/image hypoxic cancers, and different agents targeting hCA IX are currently in Phase I - III clinical trials. Among novel chemotypes, coumarins and their congeners were shown to be potent and selective hCA IX inhibitors (CAI) in vitro with an alternative mechanism of action in respect to sulfonamide-based inhibitors. Furthermore, treatment of mice harboring CA IX-positive 4T1 mammary tumors with these selective coumarin-based CA IX inhibitors resulted in significant reduction of tumor growth and metastasis formation in both spontaneous and experimental models of metastasis.
Simone Carradori
Related Documents :
24725129 - In vitro and in vivo evaluation of antitumor drug -loaded aptamer targeted single-walle...
17912429 - Rnai-mediated abrogation of cathepsin b and mmp-9 gene expression in a malignant mening...
12702139 - Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin c...
24402639 - A novel diagnostic method targeting genomic instability in intracystic tumors of the br...
23846929 - Neuroendocrine tumors: treatment updates.
25007399 - [111in-dota]ltt-ss28, a first pansomatostatin radioligand for in vivo targeting of soma...
9761939 - Fibrinolytic activity of earthworms extract (g-90) on lysis of fibrin clots originated ...
17961029 - Cyclic cushing syndrome: definitions and treatment implications.
17090199 - Primary angiosarcoma of the bladder.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-7
Journal Detail:
Title:  Expert opinion on therapeutic patents     Volume:  -     ISSN:  1744-7674     ISO Abbreviation:  Expert Opin Ther Pat     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9516419     Medline TA:  Expert Opin Ther Pat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Sapienza University of Rome, Department of Drug Chemistry and Technologies , P.le A. Moro 5, 00185 Rome , Italy +0039 06 4969 3242 ; +0039 06 4969 3923 ;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optimum cooking conditions for shrimp and atlantic salmon.
Next Document:  Evidence-Based Practice Process Quality Assessment: EPQA Guidelines.